Pieris Pharmaceuticals Stock Forecast

Pieris Pharmaceuticals stock upgraded from Hold/Accumulate to Buy Candidate after Wednesday trading session.
(Updated on Apr 24, 2024)

PIRS Signals & Forecast

The Pieris Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $3.53 and $0.85. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, April 23, 2024, and so far it has fallen -0.583%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Pieris Pharmaceuticals stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.760 between high and low, or 6.80%. For the last week the stock has had daily average volatility of 10.32%.

The Pieris Pharmaceuticals stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $11.54 (-3.24%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 99 and this increases the risk substantially. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (PIRS) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Pieris Pharmaceuticals to open at $11.68, and during the day (based on 14 day Average True Range), to move between $11.01 and $12.85, which gives a possible trading interval of +/-$0.92 (+/-7.71%) up or down from last closing price. If Pieris Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 15.42% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $12.00, some $0.0700 (0.59%) from the current price of $11.93, our system finds the risk reward not very attractive.

Is Pieris Pharmaceuticals stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Pieris Pharmaceuticals stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 1.433 Buy Candidate Upgraded

Predicted Opening Price for Pieris Pharmaceuticals of Thursday, April 25, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.